DE69714011D1 - Die erzeugung einer immunantwort gegen erwünschte determinanten - Google Patents

Die erzeugung einer immunantwort gegen erwünschte determinanten

Info

Publication number
DE69714011D1
DE69714011D1 DE69714011T DE69714011T DE69714011D1 DE 69714011 D1 DE69714011 D1 DE 69714011D1 DE 69714011 T DE69714011 T DE 69714011T DE 69714011 T DE69714011 T DE 69714011T DE 69714011 D1 DE69714011 D1 DE 69714011D1
Authority
DE
Germany
Prior art keywords
immune response
generation
determinants
desired determinants
provides compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69714011T
Other languages
English (en)
Other versions
DE69714011T2 (de
Inventor
L Alexander
Shawn Defrees
Alessandro Sette
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epimmune Inc
Original Assignee
Epimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epimmune Inc filed Critical Epimmune Inc
Publication of DE69714011D1 publication Critical patent/DE69714011D1/de
Application granted granted Critical
Publication of DE69714011T2 publication Critical patent/DE69714011T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/605—MHC molecules or ligands thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Control Of High-Frequency Heating Circuits (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69714011T 1996-01-24 1997-01-23 Die erzeugung einer immunantwort gegen erwünschte determinanten Expired - Lifetime DE69714011T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1051096P 1996-01-24 1996-01-24
PCT/US1997/001041 WO1997026784A1 (en) 1996-01-24 1997-01-23 Induction of immune response against desired determinants

Publications (2)

Publication Number Publication Date
DE69714011D1 true DE69714011D1 (de) 2002-08-22
DE69714011T2 DE69714011T2 (de) 2003-02-27

Family

ID=21746084

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69714011T Expired - Lifetime DE69714011T2 (de) 1996-01-24 1997-01-23 Die erzeugung einer immunantwort gegen erwünschte determinanten

Country Status (12)

Country Link
EP (1) EP0876398B1 (de)
JP (1) JP4063879B2 (de)
CN (1) CN1214051A (de)
AT (1) ATE220687T1 (de)
AU (1) AU1582797A (de)
BR (1) BR9710404A (de)
CA (1) CA2242878C (de)
DE (1) DE69714011T2 (de)
DK (1) DK0876398T3 (de)
ES (1) ES2177927T3 (de)
PT (1) PT876398E (de)
WO (1) WO1997026784A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528061B1 (en) * 1997-09-04 2003-03-04 Pasteur Institut Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions
EP1903056A3 (de) 2002-12-10 2008-05-07 Idm Pharma, Inc. HLA-A1, -A2, -A3, -A24, -B7 and -B44 bindende Peptide die Tumorassoziiert-Antigen Epitopen enthalten, und Zusammensetzungen davon
AU2003285280A1 (en) * 2002-12-11 2004-06-30 Pharmexa A/S Targeting single epitopes
US20080274129A1 (en) 2003-04-18 2008-11-06 Fikes John D Hla-A2 Tumor Associated Antigen Peptides and Compositions
ES2310072B1 (es) 2005-12-23 2009-11-16 Proyecto De Biomedicina Cima, S.L. Nuevos peptidos determinantes antigenicos t colaboradores (/dth).
WO2009025777A1 (en) * 2007-08-17 2009-02-26 University Of Maryland Carbohydrate functionalized catanionic surfactant vesicles for drug delivery
US9249187B2 (en) 2009-01-28 2016-02-02 Epimmune Inc. Pan-DR binding polypeptides and uses thereof
WO2012123269A1 (en) 2011-03-11 2012-09-20 Proyecto De Biomedicina Cima, S.L. Immunogenic compositions and methods for their use
US10588952B2 (en) * 2013-03-29 2020-03-17 Sumitomo Dainippon Pharma Co., Ltd. Conjugate vaccine using trimming function of ERAP1
ES2691091T3 (es) 2013-03-29 2018-11-23 Sumitomo Dainippon Pharma Co., Ltd. Vacuna conjugada de péptido antigénico de WT1
CA2919835A1 (en) 2013-07-31 2015-02-05 Board Of Trustees Of The University Of Arkansas Compositions for and methods of treating and preventing cancer targeting tumor associated carbohydrate antigens
CN106456766B (zh) * 2014-03-19 2020-03-10 台湾基督长老教会马偕医疗财团法人马偕纪念医院 抗免疫原性糖肽的抗体、包含其的组合物及其用途
CN107141355B (zh) * 2017-05-31 2021-05-14 中国人民解放军第四军医大学 一种htnv抗原表位线性串联多肽及表位肽-复合物四聚体和应用
CN109991422A (zh) * 2017-12-29 2019-07-09 复旦大学 基于特异抗血清的棕榈酰化修饰蛋白质的检测方法
US20230181721A1 (en) 2020-05-11 2023-06-15 Ose Immunotherapeutics Vaccine against sars-cov virus
AU2021311894A1 (en) 2020-07-22 2023-02-02 3H Bio. Co., Ltd. Peptide for immunotherapeutic agent
KR102261457B1 (ko) * 2020-07-22 2021-06-09 (주)쓰리에이치바이오 면역 치료제용 펩타이드
WO2022268916A2 (en) 2021-06-23 2022-12-29 Ose Immunotherapeutics Pan-coronavirus peptide vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2157510A1 (en) * 1993-03-05 1994-09-15 Howard M. Grey Hla-a2.1 binding peptides and their uses
JP3926839B2 (ja) * 1993-09-14 2007-06-06 エピミューン，インコーポレイティド 万能ｄｒ−結合性ペプチドを用いる免疫応答の改変

Also Published As

Publication number Publication date
PT876398E (pt) 2002-12-31
ATE220687T1 (de) 2002-08-15
CN1214051A (zh) 1999-04-14
DK0876398T3 (da) 2002-08-12
CA2242878A1 (en) 1997-07-31
AU1582797A (en) 1997-08-20
EP0876398A1 (de) 1998-11-11
BR9710404A (pt) 1999-08-17
WO1997026784A1 (en) 1997-07-31
CA2242878C (en) 2010-06-22
JP4063879B2 (ja) 2008-03-19
JP2000504328A (ja) 2000-04-11
EP0876398B1 (de) 2002-07-17
DE69714011T2 (de) 2003-02-27
ES2177927T3 (es) 2002-12-16

Similar Documents

Publication Publication Date Title
DE69714011T2 (de) Die erzeugung einer immunantwort gegen erwünschte determinanten
DE69929444D1 (de) Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung
CY1108211T1 (el) Προφυλακτικη και θεραπευτικη αγωγη των μολυσματικων, αυτοανοσων και αλλεργικων νοσων με ενωσεις βασης μονοσακχαριτη
BR0313587A (pt) composições imunoestimuladoras e métodos de estimulação de uma resposta imune
DK0814836T3 (da) Vaccineadjuvanser
CY1108074T1 (el) Ανοσολογικες μεθοδοι για τη ρυθμιση της μυοστατινης σε σπονδυλωτα
PL336580A1 (en) Fine-molecular compounds useful in treating inflammatory diseases
NO964238L (no) Halofantrin-fri-base for behandling av malaria og blandinger
BG102623A (en) New derivatives of benzoylguanadine, methods for their preparation and application for the manufacture of medicamentous forms
ATE413888T1 (de) Salmonella vakzine
DK1146906T3 (da) Mukosalt afgivelsessystem
BG104291A (en) 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
DK0787135T3 (da) Vandopløslige derivater af epipodophyllotoxin, fremgangsmåde til fremstilling deraf og anvendelse som et lægemiddel til beh
ITRM920078A1 (it) Connettore elettrico e metodo per produrlo.
FR2715304B1 (fr) Vaccin anti-allergique.
ATE210989T1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
DE69637435D1 (de) Saponin-zusammensetzungen und deren verwendung
BG105372A (en) Immunogenic liposome compositions
DK0858345T3 (da) Anvendelse af muteiner af vildtypecytokiner som immunogener
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
EP1555316A3 (de) Antigenbibliothek Immunisierung
UA36540A (uk) Спосіб проведення кліматооздоровчих процедур з використанням галотерапії та установка для його здійснення
UA36485A (uk) Спосіб лікування генералізованого пародонтиту
ITMI950729A1 (it) Uso della lisofosfatidilcolina nel campo della riproduzione umana
HUP9800094A2 (hu) Nem patogén mutáns E. coli törzsek, előállításuk és alkalmazásuk

Legal Events

Date Code Title Description
8364 No opposition during term of opposition